Stock Earnings

Question 1

Quels sont les états financiers clés de Voyager Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Voyager Therapeutics Inc a un total d'actifs de $393, un bénéfice net loss de $-65

Question 2

Quels sont les ratios financiers clés pour VYGR ?

Accepted Answer

Le ratio de liquidité de Voyager Therapeutics Inc est 4.22, la marge nette est -81.25, les ventes par action sont de $1.38.

Question 3

Comment les revenus de Voyager Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Voyager Therapeutics Inc data is not available.

Question 4

Voyager Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Voyager Therapeutics Inc a un bénéfice net loss de $-65

Question 5

Voyager Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Voyager Therapeutics Inc a un passif de 93

Question 6

Combien d'actions en circulation Voyager Therapeutics Inc a-t-elle ?

Accepted Answer

Voyager Therapeutics Inc a un total d'actions en circulation de 54.73

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	42	80	250	40	37	171
Revenue Growth (YoY)	-71%	-68%	525%	8%	-78%	64%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	37	35	35	31	37	35
Research & Development	128	124	92	60	73	108
Operating Expenses	165	160	127	91	111	143
Other Non Operating Income (Expenses)	1	0	0	2	2	7
Pretax Income	-107	-64	133	-46	-71	36
Income Tax Expense	0	0	1	0	--	0
Net Income	-107	-65	132	-46	-71	36
Net Income Growth	-1,289%	-149%	-387%	-35%	-297%	-184%
Shares Outstanding (Diluted)	58.66	57.66	44.56	38.4	37.7	37.3
Shares Change (YoY)	2%	28.99%	16%	2%	1%	4%
EPS (Diluted)	-1.85	-1.12	2.96	-1.21	-1.89	0.98
EPS Growth	-1,303%	-138%	-345%	-36%	-293%	-181%
Free Cash Flow	-115	-18	74	-15	-55	-108
Free Cash Flow Per Share	-1.96	-0.31	1.66	-0.39	-1.45	-2.89
Gross Margin	--	--	--	--	--	--
Operating Margin	-292.85%	-100%	48.8%	-125%	-197.29%	15.78%
Profit Margin	-254.76%	-81.25%	52.8%	-114.99%	-191.89%	21.05%
Free Cash Flow Margin	-273.8%	-22.5%	29.59%	-37.5%	-148.64%	-63.15%
EBITDA	-119	-76	126	-44	-68	30
EBITDA Margin	-283.33%	-95%	50.4%	-110%	-183.78%	17.54%
D&A For EBITDA	4	4	4	6	5	3
EBIT	-123	-80	122	-50	-73	27
EBIT Margin	-292.85%	-100%	48.8%	-125%	-197.29%	15.78%
Effective Tax Rate	0%	0%	0.75%	0%	--	0%

Voyager Therapeutics Inc (VYGR) Price